SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-001216
Filing Date
2011-02-24
Accepted
2011-02-24 18:32:09
Documents
1
Period of Report
2011-02-22

Document Format Files

Seq Description Document Type Size
1 c64531_4.html 4  
1 c64531_4.xml 4 3656
  Complete submission text file 0000930413-11-001216.txt   5708
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
Business Address
LEBUHN ROBERT (Reporting) CIK: 0001007931 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 11637998